Alex Azar @SecAzar
CARB-X’s first 2 years have exceeded expectations already, with 33 investigational drugs, including 10 new classes… https://t.co/dxUc0Z8UgO — PolitiTweet.org
CDC Emerging Infections @CDC_NCEZID
CARB-X is investing in innovations worldwide to ensure we can protect patients from #AntibioticResistance.… https://t.co/PN93CzZCb7